spacer
home > white papers > Tabletability, Compactability, and Compressibilty: What’s the Difference? - Natoli Engineering Company, Inc.
WHITE PAPERS
logo_Natoli_Engo.jpg

Natoli Engineering Company, Inc.

phone +1 636 926 8900
email info@natoli.com
web http://www.natoli.com
email 28 Research Park Circle, Saint Charles, MO 63304, US

Tabletability, Compactability, and Compressibilty: What’s the Difference?

To patients and consumers, tablets are a simple and convenient dosage form. But the science behind compressing a block of particles or granules into a single tablet can be complicated. That’s where common compression studies can help. This article explains how to develop tabletability, compactibility, and compressibility profiles.
Tabletability, Compactability, and Compressibilty: What’s the Difference?
spacer

Member login

E-mail address:

Password:
Remember me


News and Press Releases

Show germs the final curtain

Teknomek’s PVC strip curtains are renowned for helping reduce hygiene risk by keeping differently graded areas within cleanrooms separate. The company has now extended this protection by adding anti-microbial protection embedded within the PVC to prevent the growth of bacteria, including MRSA, and further minimising the risk of cross-contamination. The anti-microbial curtains are built to last, with silver ions incorporated during the manufacturing process, providing significantly greater microbial resistance. The hard-wearing curtains suitable for use in temperatures of +38°C to - 10°C.
More info >>


White Papers

Orthogonal Approaches for the Analysis of Protein Sequence

Ludger Ltd

One of the most important classes of biopharmaceuticals is monoclonal antibodies. They are expressed from living cells, and are consequently subject to complex biochemical pathways. Not all of these routes are fully understood, and many are sensitive to the subtlest of environmental changes. Changes such as these can affect the final biopharmaceutical sequence, structure and post-translational modifications, not to mention any changes that may occur during further purification. This often means that the final product from one batch may be different from the last in another batch. Each batch is a complicated mix of similar molecules, and analysis of the degree of batch-to-batch variation is therefore very important to the establishment of the drug's safety for medicinal use and patient administration.
More info >>


Industry Events

T3: Trials, Tech and Transformation

30-31 May 2018, Raleigh Convention Center, Raleigh, NC

T3 is back for 2018 to provide you with the latest updates and top tips from across the clinical trials landscape. Connecting leading experts, influencers and innovators from pharma, biotech, CROs, patient advocacy groups, academia and beyond, T3 is themeeting place for all stakeholders to voice their questions, connect with peers, and get direct feedback from an expert speaker line-up.And this year, we're in Raleigh.
More info >>


©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement